Maqsadli SGLT2i (Dapagliflozin) va Finerenon CKD terapiyasi

Click to Expand

CKD va buyrak etishmovchiligini boshqarish Fullscreen View

Clinical Summary

Klinik sharh va kasallik haqida maʼlumot

Dalillarga asoslangan CKD bosqich 1-5 sekinlashtirish protokoli SGLT2 inhibitörleri va steroid bo'lmagan MRAlar yordamida.

Clinical Insight: Undergoing ckd va buyrak etishmovchiligini boshqarish at our accredited centers provides international patients with access to state-of-the-art navigation robotics, intraoperative neuromonitoring, and world-renowned surgical teams at a fraction of Western costs.

Clinical Manifestations

Belgilar va alomatlar

Dastlabki alomatlar

• • Early urological symptoms
• • Mild Protein in urine, elevated serum creatinine, hypertension

Umumiy alomatlar

• • Persistent Protein in urine, elevated serum creatinine, hypertension
• • Urinary dysfunction or flank pain
• • Blood in urine or elevated creatinine

Shoshilinch alomatlar

• • Acute urinary retention or urosepsis with high fever

Etiology & Demographics

Sabablari va xavf omillari

Asosiy sabablar

• Chronic Kidney Disease (CKD Stage 1-5)
• Prostate enlargement, stone disease, or renal neoplasm
• Glomerular filtration loss

Kimlar yuqori xavf guruhida?

• Patients diagnosed with Chronic Kidney Disease (CKD Stage 1-5)
• Patients requiring expert urological surgical care

Pre-Operative Protocol

Tashxis va tekshiruvlar

Tashxis testi	Klinik maqsadi / Natijalar
Non-Contrast CT KUB / mpMRI Assessment for CKD & kidney failure management	High-resolution anatomical imaging and renal functional evaluation

Surgical Techniques

Keng qamrovli davolash variantlari

Minimally Invasive: Laser / Robotic Urological Protocol for CKD & kidney failure management

Primary Choice

Board-certified urologist executed procedure.

Asosiy afzalliklari:

Incisionless endoscopic or robotic keyhole precision

Preserves renal function & continence

High success rate

Multidisciplinary Urological Care for CKD & kidney failure management

Complex Cases

Comprehensive open urological surgery or hemodialysis protocol.

Tavsiya etiladi:

Complex urological pathology

Advanced renal disease

Hamkor shifoxonalardagi zamonaviy tibbiy texnologiyalar

da Vinci Xi Urological Robot Thulium Laser Stone Dusting HoLEP Enucleation

Clinical Risk Warning

Davolanmaslikning asoratlari

Transient hematuria

Catheter discomfort

Post-op adaptation

Post-Operative Milestone

Tiklanish grafigi, parhez va turmush tarzi

Tiklanish vaqti

Prosedura / Bosqich	Kutilayotgan tiklanish muddati
Post-Procedure Recovery	24 to 48 hours
Catheter / Stent Removal	3 to 7 days
Full Active Living	2 to 3 weeks

Davolashdan keyingi parhez

• High fluid intake (> 3.0L water/day)
• Low sodium balanced diet

Turmush tarzini oʻzgartirish

• Avoid heavy lifting > 5kg for 4 weeks
• Complete prescribed antibiotic course

Zudlik bilan shifokorga murojaat qilish belgilari:

High fever > 100.4°F with chills

Inability to void urine

Heavy blood clots

Long-Term Health

Oldini olish va uzoq muddatli salomatlik

Hydration > 2.5L daily and annual PSA / kidney function checkups

Transparent Benchmark

Jahon boʻyicha narxlar solishtirmasi

Prosedura	USA (Avg)	India (ISG Network)	Turkey (Avg)	Thailand (Avg)
CKD va buyrak etishmovchiligini boshqarish	$35,000	$1,500	$8,500	$9,500

Patient Knowledgebase

Koʻp beriladigan savollar

What is the goal of treatment for CKD & kidney failure management?

The main goal is preserving renal function and restoring normal urological function under board-certified urologists.